BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 35229346)

  • 1. Immunoglobulin A vasculitis post-severe acute respiratory syndrome coronavirus 2 vaccination and review of reported cases.
    Hashizume H; Ajima S; Ishikawa Y
    J Dermatol; 2022 May; 49(5):560-563. PubMed ID: 35229346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary immunoglobulin A nephropathy with gross hematuria leading to rapidly progressive glomerulonephritis following severe acute respiratory syndrome coronavirus 2 vaccination: a case report.
    Fukuda M; Kaneko T; Kawai T; Ishii H; Shimizu A
    BMC Nephrol; 2023 Aug; 24(1):232. PubMed ID: 37553599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sibling cases of gross hematuria and newly diagnosed IgA nephropathy following SARS-CoV-2 vaccination.
    Uchiyama Y; Fukasawa H; Ishino Y; Nakagami D; Kaneko M; Yasuda H; Furuya R
    BMC Nephrol; 2022 Jun; 23(1):216. PubMed ID: 35729514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gross hematuria can be an impact of severe acute respiratory syndrome coronavirus 2 vaccination on immunoglobulin A nephropathy: a case report.
    Kanamori H
    J Med Case Rep; 2022 Jul; 16(1):273. PubMed ID: 35818083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronavirus disease 2019, vaccination against coronavirus and immunoglobulin A-mediated diseases: systematic literature review.
    Bronz G; Faré PB; Lava SAG; Bianchetti MG; Simonetti GD; Scoglio M; Beretta-Piccoli BT; Agostoni C; Milani GP
    J Autoimmun; 2022 Oct; 132():102899. PubMed ID: 36108473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgA nephropathy with glomerular capillary IgA deposition following SARS-CoV-2 mRNA vaccination: a report of three cases.
    Yokote S; Ueda H; Shimizu A; Okabe M; Yamamoto K; Tsuboi N; Yokoo T
    CEN Case Rep; 2022 Nov; 11(4):499-505. PubMed ID: 35562631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New-onset IgA nephropathy following COVID-19 vaccination.
    Ma Y; Xu G
    QJM; 2023 Feb; 116(1):26-39. PubMed ID: 35920797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of IgA vasculitis with severe glomerulonephritis after COVID-19 vaccination: a case report and literature review.
    Sugita K; Kaneko S; Hisada R; Harano M; Anno E; Hagiwara S; Imai E; Nagata M; Tsukamoto Y
    CEN Case Rep; 2022 Nov; 11(4):436-441. PubMed ID: 35275366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgA vasculitis following COVID-19 vaccination.
    Nishimura N; Shiomichi Y; Takeuchi S; Akamine S; Yoneda R; Yoshizawa S
    Mod Rheumatol Case Rep; 2023 Jan; 7(1):122-126. PubMed ID: 35253880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo IgA nephropathy in a kidney transplant recipient after SARS-CoV-2 vaccination.
    Alonso M; Villanego F; Segurado Ó; Vigara LA; Orellana C; García T; Mazuecos A
    Nefrologia (Engl Ed); 2024; 44(2):277-279. PubMed ID: 38641488
    [No Abstract]   [Full Text] [Related]  

  • 11. A Case of Leukocytoclastic Vasculitis Following SARS-COV-2 Vaccination.
    Ball-Burack MR; Kosowsky JM
    J Emerg Med; 2022 Aug; 63(2):e62-e65. PubMed ID: 35690533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronavirus disease 2019-associated immunoglobulin A vasculitis/Henoch-Schönlein purpura: A case report and review.
    Jedlowski PM; Jedlowski MF
    J Dermatol; 2022 Jan; 49(1):190-196. PubMed ID: 34741345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abrupt worsening of occult IgA nephropathy after the first dose of SARS-CoV-2 vaccination.
    Fujita Y; Yoshida K; Ichikawa D; Shibagaki Y; Yazawa M
    CEN Case Rep; 2022 Aug; 11(3):302-308. PubMed ID: 34988883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Onset Biopsy-Proven Nephropathies after COVID Vaccination.
    Fenoglio R; Lalloni S; Marchisio M; Oddone V; De Simone E; Del Vecchio G; Sciascia S; Roccatello D
    Am J Nephrol; 2022; 53(4):325-330. PubMed ID: 35354140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-COVID-19 vaccination IgA vasculitis in an adult.
    Grossman ME; Appel G; Little AJ; Ko CJ
    J Cutan Pathol; 2022 Apr; 49(4):385-387. PubMed ID: 34779011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin A Vasculitis Following COVID-19: A French Multicenter Case Series.
    Ramdani Y; Galempoix JM; Augusto JF; Dekmeer E; Perard L; Ferreira N; Bigot A; Magnant J; Jobard S; Diot E; Besse MC; Henrique H; Maillot F; Audemard-Verger A
    J Rheumatol; 2022 Dec; 49(12):1390-1394. PubMed ID: 36243405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New-onset systemic vasculitis following SARS-CoV-2 infection and vaccination: the trigger, phenotype, and outcome.
    Mv P; Auanassova A; Yessirkepov M; Zimba O; Gasparyan AY; Kitas GD; Ahmed S
    Clin Rheumatol; 2023 Oct; 42(10):2761-2775. PubMed ID: 37422611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of renal histopathology in three patients with gross hematuria after SARS-CoV-2 vaccination.
    Ota K; Yonekura Y; Saigan M; Goto K; Nishi S
    CEN Case Rep; 2023 May; 12(2):176-183. PubMed ID: 36219335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 Vaccination as a Trigger of IgA Vasculitis: A Global Pharmacovigilance Study.
    Ramdani Y; Largeau B; Jonville-Bera AP; Maillot F; Audemard-Verger A
    J Rheumatol; 2023 Apr; 50(4):564-567. PubMed ID: 36379583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 vaccination-induced cutaneous vasculitis: Report of two new cases and literature review.
    Abdelmaksoud A; Wollina U; Temiz SA; Hasan A
    Dermatol Ther; 2022 Jun; 35(6):e15458. PubMed ID: 35306713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.